Annual Accounts Payable
$974.60 K
+$419.90 K+75.70%
June 1, 2024
Summary
- As of February 7, 2025, GENE annual accounts payable is $974.60 thousand, with the most recent change of +$419.90 thousand (+75.70%) on June 1, 2024.
- During the last 3 years, GENE annual accounts payable has risen by +$772.00 thousand (+381.05%).
- GENE annual accounts payable is now -57.39% below its all-time high of $2.29 million, reached on June 30, 2005.
Performance
GENE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$974.60 K
-$331.20 K-25.36%
June 1, 2024
Summary
- As of February 7, 2025, GENE quarterly accounts payable is $974.60 thousand, with the most recent change of -$331.20 thousand (-25.36%) on June 1, 2024.
- Over the past year, GENE quarterly accounts payable has increased by +$419.90 thousand (+75.70%).
- GENE quarterly accounts payable is now -57.39% below its all-time high of $2.29 million, reached on June 30, 2005.
Performance
GENE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
GENE Accounts Payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +75.7% | +75.7% |
3 y3 years | +381.1% | +75.7% |
5 y5 years | +135.8% | +75.7% |
GENE Accounts Payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +381.1% | -42.1% | +75.7% |
5 y | 5-year | at high | +381.1% | -42.1% | +381.1% |
alltime | all time | -57.4% | +381.1% | -57.4% | +381.1% |
Genetic Technologies Limited Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | $974.60 K(+75.7%) | $974.60 K(-25.4%) |
Dec 2023 | - | $1.31 M(+135.4%) |
Jun 2023 | $554.70 K(-30.1%) | $554.70 K(-67.0%) |
Dec 2022 | - | $1.68 M(+112.0%) |
Jun 2022 | $793.70 K(+291.8%) | $793.70 K(-23.7%) |
Dec 2021 | - | $1.04 M(+413.8%) |
Jun 2021 | $202.60 K(-15.8%) | $202.60 K(-47.6%) |
Dec 2020 | - | $386.50 K(+60.6%) |
Jun 2020 | $240.60 K(-41.8%) | $240.60 K(-52.8%) |
Dec 2019 | - | $509.30 K(+23.2%) |
Jun 2019 | $413.40 K(+5.0%) | $413.40 K(-2.5%) |
Dec 2018 | - | $424.10 K(+7.7%) |
Jun 2018 | $393.70 K(+28.6%) | $393.70 K(-20.3%) |
Dec 2017 | - | $493.70 K(+61.3%) |
Jun 2017 | $306.10 K(+4.5%) | $306.10 K(-63.1%) |
Dec 2016 | - | $828.60 K(+182.8%) |
Jun 2016 | $293.00 K(-26.1%) | $293.00 K(-35.3%) |
Dec 2015 | - | $452.80 K(+14.2%) |
Jun 2015 | $396.60 K | $396.60 K(-53.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | - | $846.40 K(-0.1%) |
Jun 2014 | $847.60 K(+46.8%) | $847.60 K(-35.9%) |
Dec 2013 | - | $1.32 M(+129.0%) |
Jun 2013 | $577.40 K(+73.0%) | $577.40 K(+73.0%) |
Jun 2012 | $333.70 K(-52.2%) | $333.70 K(-52.2%) |
Jun 2011 | $698.00 K(-30.6%) | $698.00 K(-41.0%) |
Dec 2010 | - | $1.18 M(+17.6%) |
Jun 2010 | $1.01 M(-42.2%) | $1.01 M(-42.2%) |
Jun 2009 | $1.74 M(+1.7%) | $1.74 M(+36.1%) |
Dec 2008 | - | $1.28 M(-25.3%) |
Jun 2008 | $1.71 M(+29.1%) | $1.71 M(+33.0%) |
Dec 2007 | - | $1.29 M(-2.9%) |
Jun 2007 | $1.33 M(+26.6%) | $1.33 M(-10.7%) |
Dec 2006 | - | $1.48 M(+41.8%) |
Jun 2006 | $1.05 M(-54.2%) | $1.05 M(+5.6%) |
Dec 2005 | - | $991.80 K(-56.6%) |
Jun 2005 | $2.29 M(+63.8%) | $2.29 M(+28.4%) |
Dec 2004 | - | $1.78 M |
Jun 2004 | $1.40 M(+50.5%) | - |
Jun 2003 | $927.90 K | - |
FAQ
- What is Genetic Technologies Limited annual accounts payable?
- What is the all time high annual accounts payable for Genetic Technologies Limited?
- What is Genetic Technologies Limited annual accounts payable year-on-year change?
- What is Genetic Technologies Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for Genetic Technologies Limited?
- What is Genetic Technologies Limited quarterly accounts payable year-on-year change?
What is Genetic Technologies Limited annual accounts payable?
The current annual accounts payable of GENE is $974.60 K
What is the all time high annual accounts payable for Genetic Technologies Limited?
Genetic Technologies Limited all-time high annual accounts payable is $2.29 M
What is Genetic Technologies Limited annual accounts payable year-on-year change?
Over the past year, GENE annual accounts payable has changed by +$419.90 K (+75.70%)
What is Genetic Technologies Limited quarterly accounts payable?
The current quarterly accounts payable of GENE is $974.60 K
What is the all time high quarterly accounts payable for Genetic Technologies Limited?
Genetic Technologies Limited all-time high quarterly accounts payable is $2.29 M
What is Genetic Technologies Limited quarterly accounts payable year-on-year change?
Over the past year, GENE quarterly accounts payable has changed by +$419.90 K (+75.70%)